0 Table of Contents |
1 Home |
2 Changes |
3 Copyrights |
4 Datatypes |
5 Design Conventions |
6 Downloads |
7 Examples |
8 General Principles |
9 Generation and Data Inclusion |
10 Known Issues and Future Development |
11 Privacy and Security Considerations |
12 Profiles |
13 Structure of the International Patient Summary |
14 Terminology |
15 Artifacts Summary |
15.1 IPS Server Capability Statement |
15.2 IPS Summary |
15.3 Address |
15.4 Address Book |
15.5 Advanced Directives |
15.6 Alerts |
15.7 Allergies and Intolerances |
15.8 Any |
15.9 Cross Organization |
15.10 Document |
15.11 Functional Status |
15.12 Healthcare Provider |
15.13 History of Past Problems |
15.14 History of Pregnancy |
15.15 History of Procedures |
15.16 Immunizations |
15.17 ISO 27269 IPS |
15.18 Medical Devices |
15.19 Medication Summary |
15.20 Name |
15.21 Patient |
15.22 Patient Story |
15.23 Patient's address book |
15.24 Person Name |
15.25 Plan of Care |
15.26 Problems |
15.27 Results |
15.28 Social History |
15.29 Telecom |
15.30 Telecom |
15.31 Vital Signs |
15.32 AllergyIntolerance (IPS) |
15.33 Bundle (IPS) |
15.34 Composition (IPS) |
15.35 Condition (IPS) |
15.36 Device (IPS) |
15.37 Device - Performer or Observer (IPS) |
15.38 DeviceUseStatement (IPS) |
15.39 DiagnosticReport (IPS) |
15.40 Flag - Alert (IPS) |
15.41 ImagingStudy (IPS) |
15.42 Immunization (IPS) |
15.43 Medication (IPS) |
15.44 MedicationRequest (IPS) |
15.45 MedicationStatement (IPS) |
15.46 Observation Pregnancy - Expected Delivery Date (IPS) |
15.47 Observation Pregnancy - Outcome (IPS) |
15.48 Observation Pregnancy - Status (IPS) |
15.49 Observation Results - Laboratory/Pathology (IPS) |
15.50 Observation Results - Radiology (IPS) |
15.51 Observation Social History - Alcohol Use (IPS) |
15.52 Observation Social History - Tobacco Use (IPS) |
15.53 Organization (IPS) |
15.54 Patient (IPS) |
15.55 Practitioner (IPS) |
15.56 PractitionerRole (IPS) |
15.57 Procedure (IPS) |
15.58 Specimen (IPS) |
15.59 Codeable Concept (IPS) |
15.60 Coding with translations |
15.61 Quantity (IPS) |
15.62 Range (IPS) |
15.63 Ratio (IPS) |
15.64 SimpleQuantity (IPS) |
15.65 Allergy Intolerance - IPS |
15.66 Allergy Reaction - IPS |
15.67 Body Site - IPS |
15.68 Current Smoking Status - IPS |
15.69 Diagnostics Report Status Codes - IPS |
15.70 Healthcare Professional Roles - IPS |
15.71 Imaging Study Status Codes - IPS |
15.72 Medical Devices - IPS |
15.73 Medications - example (IPS) |
15.74 Medications - IPS |
15.75 Medicine Active Substances - IPS |
15.76 Medicine Doseform - IPS |
15.77 Medicine Route of Administration - IPS |
15.78 Personal Relationship - IPS [Deprecated] |
15.79 Pregnancy Expected Delivery Date Method - IPS |
15.80 Pregnancy Outcome - IPS |
15.81 Pregnancy Status - IPS |
15.82 Problem Type (LOINC) |
15.83 Problem Type - IPS |
15.84 Problems - IPS |
15.85 Procedures - IPS |
15.86 Results Coded Values Laboratory/Pathology - IPS |
15.87 Results Laboratory/Pathology Observation - IPS |
15.88 Results Radiology Measurement Observation - IPS |
15.89 Results Radiology Observation - IPS |
15.90 Results Radiology Textual Observation - IPS |
15.91 Results Specimen Collection Method - IPS |
15.92 Results Specimen Type - IPS |
15.93 Results Status Codes - IPS |
15.94 Vaccine Target Diseases - IPS |
15.95 Vaccines - IPS |
15.96 Vaccines WHO ATC - IPS |
15.97 WHO ATC - IPS |
15.98 AllergyIntolerance - Multiple Codings |
15.99 AllergyIntolerance - No Known Allergies |
15.100 AllergyIntolerance - Resolved Allergy |
15.101 Bundle - IPS with Data |
15.102 Bundle - IPS with Required Sections and Immunization |
15.103 Bundle - Minimal Complete IPS |
15.104 Bundle - No Information in Required Sections |
15.105 Composition - Minimal Sections |
15.106 Condition - Acute Myeloid Leukemia |
15.107 Device - Device Observer |
15.108 Device - No Known Devices in Use |
15.109 DeviceUseStatement - No Known Devices in Use |
15.110 DiagnosticReport - Hemoglobin |
15.111 Flag - Alert of Patient Immunocompromised |
15.112 ImagingStudy - Referred DICOM Study |
15.113 Immunization - Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg) |
15.114 Medication - Simvastatin 40 MG Disintegrating Oral Tablet |
15.115 MedicationRequest - Simvastatin Request |
15.116 MedicationStatement - Ongoing Simvastatin Treatment |
15.117 Observation - Social History Alcohol Use |
15.118 Observation: estrogen receptor in tissue example |
15.119 Observation: hemoglobin example |
15.120 Observation: imaging Chest X-ray - PA and lateral, with additional sub-observation including numeric range |
15.121 Observation: imaging CT Abdomen W contrast IV |
15.122 Observation: imaging CT Abdomen W contrast IV, sub-observations |
15.123 Observation: pregnancy edd example |
15.124 Observation: pregnancy outcome example |
15.125 Observation: pregnancy status example |
15.126 Observation: serum creatinine example |
15.127 Observation: SH tobacco use example |
15.128 Observation: urine wbc range example |
15.129 Organization - Minimal Name Only |
15.130 Organization: example |
15.131 Organization: lab example |
15.132 Patient: female patient |
15.133 Patient: male patient |
15.134 Patient: minimal example |
15.135 Practitioner example |
15.136 PractitionerRole - Minimal |
15.137 Procedure: Surgical procedure |
15.138 Specimen: example |